These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

119 related items for PubMed ID: 1279324

  • 21. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR--phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucémies (GEIL).
    Solary E, Casasnovas RO, Campos L, Béné MC, Faure G, Maingon P, Falkenrodt A, Lenormand B, Genetet N.
    Leukemia; 1992 May; 6(5):393-9. PubMed ID: 1375696
    [Abstract] [Full Text] [Related]

  • 22. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S.
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in Leukemia.
    Bloomfield CD, Shuma C, Regal L, Philip PP, Hossfeld DK, Hagemeijer AM, Garson OM, Peterson BA, Sakurai M, Alimena G, Berger R, Rowley JD, Ruutu T, Mitelman F, Dewald GW, Swansbury J.
    Cancer; 1997 Dec 01; 80(11 Suppl):2191-8. PubMed ID: 9395033
    [Abstract] [Full Text] [Related]

  • 27. Expression of heat-shock proteins is associated with major adverse prognostic factors in acute myeloid leukemia.
    Thomas X, Campos L, Mounier C, Cornillon J, Flandrin P, Le QH, Piselli S, Guyotat D.
    Leuk Res; 2005 Sep 01; 29(9):1049-58. PubMed ID: 16038731
    [Abstract] [Full Text] [Related]

  • 28. Multivariate analyses of prognostic factors in acute myeloid leukemia: relevance of cytogenetic abnormalities and CD34 expression.
    Junghanss C, Waak M, Knopp A, Kleine HD, Kundt G, Leithäuser M, Hilgendorf I, Wolff D, Casper J, Freund M.
    Neoplasma; 2005 Sep 01; 52(5):402-10. PubMed ID: 16151585
    [Abstract] [Full Text] [Related]

  • 29. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
    Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D.
    Leukemia; 1995 Feb 01; 9(2):249-53. PubMed ID: 7532767
    [Abstract] [Full Text] [Related]

  • 30. Prognostic factors in normal karyotype acute myeloid leukemia in the absence of the FLT3-ITD mutation.
    Jiang A, Jiang H, Brandwein J, Kamel-Reid S, Chang H.
    Leuk Res; 2011 Apr 01; 35(4):492-8. PubMed ID: 20684989
    [Abstract] [Full Text] [Related]

  • 31. Prognosis of older patients with acute myeloid leukemia receiving either induction or noncurative treatment: a single-center retrospective study.
    Behringer B, Pitako JA, Kunzmann R, Schmoor C, Behringer D, Mertelsmann R, Lübbert M.
    Ann Hematol; 2003 Jul 01; 82(7):381-9. PubMed ID: 12756497
    [Abstract] [Full Text] [Related]

  • 32. Immunoreactivity of MIC2 (CD99) and terminal deoxynucleotidyl transferase in bone marrow clot and core specimens of acute myeloid leukemias and myelodysplastic syndromes.
    Kang LC, Dunphy CH.
    Arch Pathol Lab Med; 2006 Feb 01; 130(2):153-7. PubMed ID: 16454553
    [Abstract] [Full Text] [Related]

  • 33. Circulating immune complexes correlate with remission duration in acute myeloid leukemia.
    Larson RA, Lukin CL, Daly KM, Mick R, Gore S, Le Beau MM.
    Leukemia; 1991 Feb 01; 5(2):131-7. PubMed ID: 2020195
    [Abstract] [Full Text] [Related]

  • 34. Philadelphia chromosome and terminal transferase-positive acute leukemia: similarity of terminal phase of chronic myelogenous leukemia and de novo acute presentation.
    Jain K, Arlin Z, Mertelsmann R, Gee T, Kempin S, Koziner B, Middleton A, Jhanwar S, Chaganti R, Clarkson B.
    J Clin Oncol; 1983 Nov 01; 1(11):669-76. PubMed ID: 6366129
    [Abstract] [Full Text] [Related]

  • 35. Terminal transferase positive acute myeloid leukemia: immunophenotypic characterization and response to induction therapy.
    Lo Coco F, Lopez M, Pasqualetti D, Montefusco E, Cafolla A, Monarca B, Sgadari C, De Rossi G.
    Hematol Oncol; 1989 Nov 01; 7(2):167-74. PubMed ID: 2646199
    [Abstract] [Full Text] [Related]

  • 36. Prognostic relevance of the expression of Tdt and CD7 in 335 cases of acute myeloid leukemia.
    Venditti A, Del Poeta G, Buccisano F, Tamburini A, Cox-Froncillo MC, Aronica G, Bruno A, Del Moro B, Epiceno AM, Battaglia A, Forte L, Postorino M, Cordero V, Santinelli S, Amadori S.
    Leukemia; 1998 Jul 01; 12(7):1056-63. PubMed ID: 9665190
    [Abstract] [Full Text] [Related]

  • 37. Terminal transferase expression in acute myeloid leukaemia: biology and prognosis.
    Gucalp R, Paietta E, Weinberg V, Papenhausen P, Dutcher JP, Wiernik PH.
    Br J Haematol; 1991 May 01; 78(1):48-54. PubMed ID: 2043481
    [Abstract] [Full Text] [Related]

  • 38. The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia.
    de Nully Brown P, Jurlander J, Pedersen-Bjergaard J, Victor MA, Geisler CH.
    Leuk Res; 1997 Oct 01; 21(10):985-95. PubMed ID: 9403009
    [Abstract] [Full Text] [Related]

  • 39. [Clinical and immunophenotyping features of CD34-positive acute nonlymphoblastic leukemia].
    Chen G, Qian L, Shen D.
    Zhonghua Nei Ke Za Zhi; 1995 Jan 01; 34(1):26-9. PubMed ID: 7541328
    [Abstract] [Full Text] [Related]

  • 40. Lymphoid lineage-associated features in acute myeloid leukaemia: phenotypic and genotypic correlations.
    Paietta E, Van Ness B, Bennett J, Racevskis J, Gucalp R, Cassileth P, Wiernik PH.
    Br J Haematol; 1992 Oct 01; 82(2):324-31. PubMed ID: 1419814
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.